By Francesco Guarascio and Ludwig Burger
Feb 10 (Reuters) - AstraZeneca is set to enlist
Germany's IDT Biologika as a contract manufacturer of its
COVID-19 vaccine, two people familiar with the matter told
Reuters, as Germany and the European Union seek to speed up an
immunisation campaign that got off to a hobbled start.
IDT Biologika, based in Dessau-Rosslau in eastern Germany,
produces viral vaccines for pharmaceutical companies, and has
suffered a recent setback in developing its own vaccine against
the coronavirus.
IDT Biologika and AstraZeneca declined to comment.
(Reporting by Ludwig Burger, editing by Kirsti Knolle)
Astrazeneca (AZN)
